Public Buy-In Of Personalized Medicine Requires Dialogue – Tufts’ Kaitin
Executive Summary
Improving the general public's understanding of drug development and delivery will be necessary to fully leverage the potential of personalized medicine, Tufts Center for the Study of Drug Development Director Kenneth Kaitin said
You may also be interested in...
PhRMA Patient Assistance Plan Is Template For Future Initiatives – BMS’ Dolan
PhRMA's Partnership for Prescription Assistance could serve as a template for future outreach efforts by the pharmaceutical industry, incoming Chairman Peter Dolan (Bristol-Myers Squibb) suggested
PhRMA’s Evidence-Based Medicine Principles Emphasize Individual Decisions
The Pharmaceutical Research & Manufacturers of America's principles for the use of evidence-based medicine emphasize that such data be used to "empower" patients and physicians
PhRMA DTC Principles Compliance To Get Independent Panel Review In 2007
PhRMA is giving itself one year to monitor member companies' implementation of its new direct-to-consumer "guiding principles" before an independent panel will begin analyzing compliance and progress